Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06797830 · ClinicalTrials.gov registry record · NA
Improving Core Strength in the Warfighter With a Novel Device
A NA study of Low Back Pain and Posture, sponsored by David Moss.
- Active
- Registry status
- NA
- Development phase
- 43
- Enrollment target
- 1
- Study location
NCT06797830: Active NA study of Low Back Pain and Posture, sponsored by David Moss.
NCT06797830 is a NA study of Low Back Pain and Posture that is active but no longer recruiting, run by David Moss. The registered enrollment target is 43 participants, below the 503-participant average among 122 other Low Back Pain trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06797830, a NA study of Low Back Pain and Posture, is active but no longer recruiting, sponsored by David Moss.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 43 participants
- Enrollment target
- 1
- Study location
Study Summary
Low back pain is one of the most common chief complaints amongst adult patients in the ambulatory clinic and emergency settings and poor core strength is a known underlying cause/perpetuator. Additionally, it is one of the most common reasons active-duty military personnel seek medical care (absolute 2015; absolute 2016; absolute 2017). Moreover, musculoskeletal conditions represent a common reason service members are placed on limited duty and considered medically not fit to deploy. The AllCore360° has the potential to prevent pain and injury, decrease pain as well as reduce duty, fitness and mobility restrictions in active-duty members with low back pain.
Primary Outcome
Providers will evaluate participants posture using the PostureScreen® mobile app. The PostureScreen® mobile app can be loaded onto an iPad or phone and used by study personnel to take photos of the subject. The software then measures postures from multiple views and produces a total of 41 with the spine data (31 without the spine data) postural measurements. These measurements are reported as anterior/lateral translations and angular displacements in a scale of inches or degrees respectively. A
Conditions Studied
Interventions
- DEVICE AllCore
Study Locations (1)
Nevada
- Mike O'Callaghan Military Medical Center - Nellis Air Force Base
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2025-01-21 |
| Est. Completion | 2027-01 |
| Phase | NA |
What the registry record for NCT06797830 still lists
NCT06797830 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 43 participants, a relatively small participant target, below the 503-participant average among 122 other Low Back Pain trials with a reported enrollment target (91% lower).
The record links to 3 conditions, with Low Back Pain appearing as the primary indexed condition, and to 1 intervention - of which AllCore is the first listed.
NCT06797830 reports a single indexed study location in Nevada.
Frequently Asked Questions
What is clinical trial NCT06797830 about?
NCT06797830 is a clinical study titled "Improving Core Strength in the Warfighter With a Novel Device". Low back pain is one of the most common chief complaints amongst adult patients in the ambulatory clinic and emergency settings and poor core strength is a known underlying cause/perpetuator. Additionally, it is one of the most common reasons active-duty military personnel seek medical care (absolut...
What is the current status of trial NCT06797830?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 43 participants. The study started on 2025-01-21. Estimated completion is 2027-01.
What conditions does trial NCT06797830 study?
This clinical trial studies the following conditions: Low Back Pain, Posture, Core Strengthening.
What interventions are being tested in trial NCT06797830?
The interventions under investigation include: AllCore (DEVICE).
Who is sponsoring clinical trial NCT06797830?
This trial is sponsored by David Moss, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06797830 being conducted?
This trial has 1 study location across Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Low Back Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06797830's enrollment target sits among peer trials
43 94th of 122 higher than 29 of 122 other Low Back Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Low Back Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Erector Spinae Plane Block for Acute Back Pain in the Emergency Department
RECRUITING · NA
-
A Multi-Site Feasibility Trial of Embedded Emergency Department Physical Therapy
RECRUITING · NA
-
Ischemic Preconditioning in Osteoarthritis and Back Pain
RECRUITING · NA
-
Feasibility of Identifying Brain Mechanisms of Qigong and Behavioral Outcomes After Qigong Practice in People With Chronic Low Back Pain
RECRUITING · NA
-
Neural Mechanisms of Meditation for Opioid-Treated Chronic Low Back Pain
RECRUITING · NA
-
Perspectives on Spinal Manipulative Therapy for Low Back Pain
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03726359 · 43 participants · Phase 1
Phase I Study of Fractionated Stereotactic Radiation Therapy
- NCT03850418 · 43 participants · Phase 2
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
- NCT04144023 · 43 participants · Phase 1
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
- NCT04176718 · 43 participants · Phase 2
Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI